Saved in:
| Main Authors: | José Rojas‐Suarez, David Correa‐Maldonado, Diego Cabarcas‐Castilla, Arnold Castro‐Giraldo, Gustavo Ahumada‐Pla |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1111/bjh.20249 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Successful management of refractory immune‐mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti‐VWF nanobody caplacizumab
by: Roman R. Schimmer, et al.
Published: (2024)
by: Roman R. Schimmer, et al.
Published: (2024)
Risk factors for silent cerebral infarction in immune‐mediated thrombotic thrombocytopenic survivors
by: Binish Javed, et al.
Published: (2025)
by: Binish Javed, et al.
Published: (2025)
Immune‐mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report
by: Masahito Uchihara, et al.
Published: (2024)
by: Masahito Uchihara, et al.
Published: (2024)
Type I interferon as a pre‐lupus marker in anti‐nuclear antibody‐associated childhood immune thrombocytopenic purpura
by: Jérôme Granel, et al.
Published: (2025)
by: Jérôme Granel, et al.
Published: (2025)
Dapsone response in immune thrombocytopenic purpura is associated with dapsone dose and mediated through reduction in haemoglobin: A longitudinal data analysis of 58 adult and paediatric ITP patients demonstrates efficacy and safety
by: Shaan D. Shah, et al.
Published: (2026)
by: Shaan D. Shah, et al.
Published: (2026)
Unveiling the responsible antigen in vaccine‐induced immune thrombotic thrombocytopenia
by: Chika Edward Uzoigwe
Published: (2025)
by: Chika Edward Uzoigwe
Published: (2025)
Monoclonal gammopathy of thrombotic significance in a nutshell
by: Adam J. Kanack, et al.
Published: (2026)
by: Adam J. Kanack, et al.
Published: (2026)
Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency
by: Erin L. Frost, et al.
Published: (2024)
by: Erin L. Frost, et al.
Published: (2024)
Association of human leucocyte antigen loci with vaccine‐induced immune thrombotic thrombocytopenia: Potential role of the interaction between platelet factor 4‐derived peptides and MHC‐II
by: Eleonora Petito, et al.
Published: (2024)
by: Eleonora Petito, et al.
Published: (2024)
Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study
by: Qing Wen, et al.
Published: (2024)
by: Qing Wen, et al.
Published: (2024)
Efficacy of radiotherapy for haemostasis in tumour‐related bleeding
by: Emma P. DeLoughery, et al.
Published: (2024)
by: Emma P. DeLoughery, et al.
Published: (2024)
Thrombotic and bleeding complications in patients with AL amyloidosis
by: Despina Fotiou, et al.
Published: (2024)
by: Despina Fotiou, et al.
Published: (2024)
Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation—A secondary CIBMTR analysis
by: Michelle L. Schoettler, et al.
Published: (2024)
by: Michelle L. Schoettler, et al.
Published: (2024)
Endothelial activation and stress index score as a predictor of transplant‐associated thrombotic microangiopathy in patients with sickle cell disease
by: Reethu Krishnan, et al.
Published: (2026)
by: Reethu Krishnan, et al.
Published: (2026)
Evans syndrome in pregnancy and the postpartum period: A retrospective cohort study
by: Debbie Jiang, et al.
Published: (2025)
by: Debbie Jiang, et al.
Published: (2025)
Service evaluation of R90 bleeding and platelet disorders gene panel in thrombocytopenia cases
by: G. Gurumurthy, et al.
Published: (2024)
by: G. Gurumurthy, et al.
Published: (2024)
A case of acquired factor XI deficiency and severe bleeding tendency associated with Streptococcus pyogenes cellulitis
by: Nancy El Beayni, et al.
Published: (2024)
by: Nancy El Beayni, et al.
Published: (2024)
The British Journal of Haematology celebrates its 70th birthday. Part one: Malignant haematology 2018–2024
by: Arnold Ganser
Published: (2025)
by: Arnold Ganser
Published: (2025)
Greater prevalence of anaemia and heavy menstrual bleeding reported in women of reproductive age in the United Kingdom compared to Australia
by: Beth MacLean, et al.
Published: (2025)
by: Beth MacLean, et al.
Published: (2025)
Pre‐infusion cytomegalovirus T‐cell immunity for predicting the risk of virus DNAemia in patients undergoing chimeric antigen receptor T‐cell therapies
by: Eliseo Albert, et al.
Published: (2025)
by: Eliseo Albert, et al.
Published: (2025)
MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia
by: Zhenyu Liu, et al.
Published: (2026)
by: Zhenyu Liu, et al.
Published: (2026)
Suboptimal screening and correction of maternal iron deficiency anaemia in the general population and in inherited bleeding disorders: A population‐based cohort study
by: Arafat Ul Alam, et al.
Published: (2026)
by: Arafat Ul Alam, et al.
Published: (2026)
Early M‐protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high‐risk cytogenetic multiple myeloma
by: Huihui Zhu, et al.
Published: (2024)
by: Huihui Zhu, et al.
Published: (2024)
Feasibility of plasma proteomics in patients with immune thrombocytopenia
by: Rick Kapur
Published: (2024)
by: Rick Kapur
Published: (2024)
Successful autologous haematopoietic stem cell transplantation in a refractory anti‐myelin‐associated glycoprotein antibody neuropathy
by: Fanny Urbain, et al.
Published: (2024)
by: Fanny Urbain, et al.
Published: (2024)
Anti‐ CD38 therapy in immune thrombocytopenia ( ITP )
by: Waleed Ghanima, et al.
Published: (2026)
by: Waleed Ghanima, et al.
Published: (2026)
Predictors of response to emergent therapies in paediatric immune thrombocytopenia
by: Candelaria O'Farrell, et al.
Published: (2025)
by: Candelaria O'Farrell, et al.
Published: (2025)
When is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia?
by: Sydney Dubois, et al.
Published: (2024)
by: Sydney Dubois, et al.
Published: (2024)
Cognitive impairment among patients with chronic immune thrombocytopenia
by: David J. Kuter, et al.
Published: (2024)
by: David J. Kuter, et al.
Published: (2024)
The Menin story in acute myeloid leukaemia—The road to success
by: Michael W. M. Kühn, et al.
Published: (2024)
by: Michael W. M. Kühn, et al.
Published: (2024)
COVID‐19 vaccination in splenectomized patients with immune thrombocytopenia—Response
by: Xiang Liu, et al.
Published: (2024)
by: Xiang Liu, et al.
Published: (2024)
COVID‐19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence
by: Hinpetch Daungsupawong, et al.
Published: (2024)
by: Hinpetch Daungsupawong, et al.
Published: (2024)
Longitudinal plasma proteomics in romiplostim‐treated patients with immune thrombocytopenia
by: Vivianne S. Nelson, et al.
Published: (2025)
by: Vivianne S. Nelson, et al.
Published: (2025)
Current gynaecological management of women and girls with bleeding disorders in the United Kingdom : A UKHCDO haemophilia treatment centre survey and evaluation of real‐world clinical practice for the British Journal of Haematology
by: Laura Knox, et al.
Published: (2025)
by: Laura Knox, et al.
Published: (2025)
Is there a role for eltrombopag drug levels in paediatric immune thrombocytopenia management?
by: Clara Lo
Published: (2024)
by: Clara Lo
Published: (2024)
Long‐term efficacy and safety of hetrombopag in paediatric patients with immune thrombocytopenia
by: Jin‐Hua Wang, et al.
Published: (2026)
by: Jin‐Hua Wang, et al.
Published: (2026)
Particular dysregulation of ‘don't eat me’ immune checkpoints in haemophagocytic lymphohistiocytosis
by: Thomas Menter, et al.
Published: (2025)
by: Thomas Menter, et al.
Published: (2025)
Decoding immune‐driven erythroid failure in pure red cell aplasia
by: Federico Spataro, et al.
Published: (2026)
by: Federico Spataro, et al.
Published: (2026)
Red blood cell immunization as an independent predictor of survival in the myelodysplastic syndromes
by: Alexandra Pedraza, et al.
Published: (2026)
by: Alexandra Pedraza, et al.
Published: (2026)
Haematopoietic stem cell transplant for inborn errors of immunity—Who and when?
by: Joseph H. Oved, et al.
Published: (2025)
by: Joseph H. Oved, et al.
Published: (2025)
Similar Items
-
Successful management of refractory immune‐mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti‐VWF nanobody caplacizumab
by: Roman R. Schimmer, et al.
Published: (2024) -
Risk factors for silent cerebral infarction in immune‐mediated thrombotic thrombocytopenic survivors
by: Binish Javed, et al.
Published: (2025) -
Immune‐mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report
by: Masahito Uchihara, et al.
Published: (2024) -
Type I interferon as a pre‐lupus marker in anti‐nuclear antibody‐associated childhood immune thrombocytopenic purpura
by: Jérôme Granel, et al.
Published: (2025) -
Dapsone response in immune thrombocytopenic purpura is associated with dapsone dose and mediated through reduction in haemoglobin: A longitudinal data analysis of 58 adult and paediatric ITP patients demonstrates efficacy and safety
by: Shaan D. Shah, et al.
Published: (2026)